Why Should You Attend:
Early regulatory uncertainty from OSHA led insurance companies to drive de facto regulation of the safe handling of nanomaterials. This webinar will help you determine how to perform reasonable risk assessments to reduce occupational safety risks for laboratory and manufacturing staff and be able to work with key stakeholders to ensure everyone becomes comfortable with identifying and compliance to best practices in an environment where using nanomaterials to improve products still creates fear around unknown aspects of nanotechnology.
Responsible commercialization and stewardship includes evaluating and mitigating the potential risks, and helping make scientific sense of peer-reviewed literature often appears to have conflicting results as headlines.
This webinar will highlight important fundamental knowledge to enter the nanomaterial risk assessment space, including understanding relevant nanomaterial measurements and how to properly interpret conflicting results in the NanoEHS literature, to understand what key factors impact or reduce safety risks. This webinar will enable attendees to use tiered approaches when performing nanomaterial and product risk assessments; take lessons learned from life cycle analysis thinking to improve processes; and identify commonly used risk mitigation approaches for handling nanomaterials.
Areas Covered in the Webinar:
Who Will Benefit:
From the following industries - Consumer Goods, Medical Devices, Dental Products and Devices, Pharmaceuticals, Cosmetics, Dietary Supplements, Contract Research Labs
Physical CD-DVD of recorded session will be despatched after 72 hrs on completion of payment
Recorded video session
Rob MacCuspie holds a Ph.D. in Nanotechnology and Materials Chemistry, and has twenty years of experience in nanotechnology research, NanoEHS, and responsible commercialization of nano-enabled products. Over his career, he has worked in the National Lab system at the National Institute of Standards and Technology, the Air Force Research Laboratory, and US FDA, as well as being first faculty at Florida Polytechnic University and Director of Nanotechnology and Multifunctional Materials Programs. He holds 1 US patent, has written 42 publications cited over 2,800 times for an h-index of 28.